Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: Wayne Rumball who wrote (22492)	5/30/1998 6:34:00 PM
From: Rob D.	Respond to of 34592

Looks like it, just saw this on CW: posted by John on May 30, 1998 at 11:08:06: I have seen alot on SI and here about this stock. I can't post on SI. But I can say the following is pretty much true. I know someone that works in one of the 2 companies in question. Sorry I can't give better proof but take it for what its worth. RECENT DEVELOPMENTS AND ANALYSIS: In 1995 the Company signed a nonexclusive licensing agreement with Archer Daniels Midland Company (ADM) for the manufacturing and sale of AstaXin(r)worldwide. On February 29, 1996, ADM informed IGENE that it would no longer use IGENE's astaxanthin technology and terminated the licensing agreement. On August 4, 1997, the Company filed a $300,450,000 contract and trade secrets lawsuit in U.S. District court in Baltimore,Maryland against ADM, contending that ADM stole the Company's formula.......